Why Argus Upgraded Vertex Pharma To Buy Last Week

By: via Benzinga
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are down 17 percent year-to-date, despite crossing the $140 mark twice ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.